Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors [1]

Journal of Medicinal Chemistry

Volumn 44, Issue 9, 2001, Pages 1334-1336

  Nugiel, D A ^a   Etzkorn, A M ^a   Vidwans, A ^a   Benfield, P A ^a   Boisclair, M ^a   Burton, C R ^a   Cox, S ^a   Czerniak, P M ^a   Doleniak, D ^a   Seitz, S P ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; FLAVOPIRIDOL; INDENOPYRAZOLE; MITOMYCIN C; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CELL ACTIVITY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LETTER; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; CYCLIN-DEPENDENT KINASES; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; MICE; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035953327     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0100032     Document Type: Letter

References (27)

1. G1 events and regulation of cell proliferation
2. Mammalian G1 Cyclins
3. Cell cycle control in eukaryotes: Molecular mechanisms of cdc2 activation
4. Cell cycle control and cancer
5. Cell cycle control and cancer
6. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
7. Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation
8. Chemical inhibitors of cyclin-dependent kinases
9. Chemical inhibitors of cyclin-dependent kinases
10. Inhibition of cyclin-dependent kinases by purine analogues
11. Exploiting chemical libraries, structure, and genomics in the search of kinase inhibitors
12. Paullones, a series of cyclin-dependent kinase inhibitors: Synthesis, evaluation of CDK1/Cyclin B inhibition, and in vitro antitumor activity
13. Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases
14. Flavopiridol (L86-8275, NSC-649890), a new kinase inhibitor for tumor therapy
15. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
16. UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: A new generation of anti-cancer agents for the new century?
17. Insecticidal properties of 1,3-indandiones